Philip Perera's most recent trade in Longboard Pharmaceuticals Inc was a trade of 95,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Longboard Pharmaceuticals Inc | Philip Perera | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 95,000 | 95,000 | - | - | Stock Option (Right to Buy) |